SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical Imaging

PUBLISHER: Marketstrat, Inc. | PRODUCT CODE: 2123813

Cover Image

PUBLISHER: Marketstrat, Inc. | PRODUCT CODE: 2123813

Global Mammography Horizon Report: Market Structure, Forecasts, Competitive Dynamics, and AI Monetization Architecture, 2024A-2035F

PUBLISHED:
PAGES: 321 Pages
DELIVERY TIME: Inquiry
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Individual License)
USD 4950
PDF (Team License)
USD 5450
PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Report Overview

Mammography remains one of the most established screening infrastructure markets in medical imaging, but it is no longer best understood as a simple equipment replacement category. Dedicated mammography systems, DBT, CEM-capable gantries, service contracts, mammography-specific workflow software, AI, breast biopsy, mobile screening, and supplemental imaging pathways are increasingly connected through the same commercial decision chain.

This Marketstrat® Horizon report analyzes the global mammography market and the broader breast imaging ecosystem from 2024A to 2035F. It separates the Core Mammography Market from the Interventional Breast Pathway and the broader Breast Imaging Ecosystem Opportunity, allowing readers to distinguish the headline system-and-service denominator from adjacent procedure, ultrasound, MRI, access, and workflow value pools.

The central commercial question is no longer only “who sells the mammography gantry?” It is: who controls the breast imaging operating system around the gantry - replacement timing, service, AI, CEM, biopsy, enterprise workflow, provider economics, mobile access, and supplemental imaging routing? The report’s competitive thesis is that durable advantage is shifting from share of gantries toward share of control planes.

This Horizon report is Marketstrat’s in-depth global analysis of mammography and breast imaging market structure. It is built for medical imaging OEM executives, breast health strategy teams, AI and workflow vendors, enterprise imaging platforms, interventional breast technology companies, investors, private equity, distributors, provider networks, and public-sector imaging leaders.

The report covers screening and diagnostic mammography, FFDM, DBT, contrast-enhanced mammography, mammography-specific software and workstations, breast AI, density and risk tools, service contracts, mobile screening, image-guided breast intervention, and supplemental breast imaging pathways. It also evaluates how value migrates across mature replacement markets, access-expansion markets, screening-program markets, China’s two-channel procurement structure, and premium private-network breast imaging pathways.

The report is designed to answer practical commercial questions:

  • Where does mammography still grow when gantry hardware is mature?
  • Which value pools sit inside the Core Mammography Market, and which sit in adjacent breast imaging pathways?
  • How should vendors think about AI monetization when provider-gross value can be larger than vendor-booked software revenue?
  • Where is CEM most commercially relevant?
  • Which companies control the installed base, service, biopsy pathway, enterprise workflow, AI layer, provider volume, and China/value-tier channels?
  • How do regional strategies differ across the U.S., Europe, China, Japan, India, LATAM, and MEA?

Market Snapshot

The global mammography market is structurally mature but strategically active. The gantry pool remains the anchor, yet the most important growth and competitive movement is occurring around the gantry: AI/workflow software, CEM-enabled diagnostic pathways, service retention, interventional breast procedures, breast ultrasound, breast MRI, mobile access infrastructure, and risk-based screening.

The report’s market architecture separates three layers:

Core Mammography Market

Dedicated mammography systems, mammography-specific service, mammography-specific software/workstations, and mammography AI/workflow.

Interventional Breast Pathway

Biopsy systems, localization, image-guided intervention, and related downstream procedure economics.

Breast Imaging Ecosystem Opportunity

The Core Mammography Market plus the Interventional Breast Pathway and breast ultrasound/MRI adjacencies.

This matters because a flat or modestly growing gantry market can still control a larger and faster-moving ecosystem. The report’s framework analysis shows equipment and service as stable, installed-base-heavy pools, while AI/workflow, CEM, breast ultrasound, breast MRI, and biopsy/intervention drive a broader strategic opportunity.

Key Market Trends

1. Mammography is shifting from hardware replacement to ecosystem control

  • The strongest competitors are not simply those with the most installed gantries. They are the companies that can defend replacement accounts, attach service, integrate AI and workflow, enable CEM, support biopsy pathways, and keep the breast imaging study inside their operating environment.

2. DBT is becoming baseline in developed markets

  • DBT remains strategically important, but in many developed markets it is increasingly a replacement-cycle and premium-standard feature rather than a greenfield growth story. Future differentiation shifts toward workflow, patient experience, AI integration, CEM readiness, dose, acquisition speed, service, and fleet economics.

3. CEM is the most important near-term premium technology overlay

  • Contrast-enhanced mammography is not yet a broad screening standard, but it is strategically important for dense-breast workup, diagnostic problem-solving, selected MRI-substitution use cases, CEM-guided biopsy, and premium breast-center positioning. The report treats CEM as a practical near-term overlay rather than a distant frontier technology.

4. AI monetization must be separated from provider economics

  • The report distinguishes vendor-net AI/workflow revenue from provider-gross economics. Vendor revenue includes software, OEM-bundled AI, SaaS, enterprise subscriptions, and per-study fees. Provider-gross value includes patient-pay add-ons, workflow productivity, recall management, reimbursement, and downstream throughput. This separation avoids double counting and clarifies who captures value.

5. Breast ultrasound and breast MRI are not inside the core denominator, but they matter commercially

  • Supplemental imaging is central to the broader breast imaging pathway. Breast ultrasound and breast MRI are treated as adjacencies rather than core mammography revenue, but they materially shape diagnostic follow-up, dense-breast workflows, high-risk pathways, provider economics, and vendor ecosystem strategy.

6. Regional strategy is not one global adoption curve

  • The report frames mammography as a local policy and procurement market with global platform economics. Adoption is shaped by screening age bands, public-program design, insurance coverage, procurement systems, workforce constraints, provider-network structure, and local service capacity.

Competitive Landscape

Marketstrat structures the mammography market into eight competitive clusters because the market is increasingly shaped by control planes rather than a flat OEM ranking.

The report analyzes:

  • Systems OEMs / breast health platform incumbents: Hologic, GE HealthCare, Siemens Healthineers, Fujifilm, Canon Medical, Planmed, IMS/Giotto, and selected regional specialists.
  • China and value-tier challengers: United Imaging, Wandong, Mindray, Neusoft, Inkon, and regional distributors.
  • Breast AI detection and second-reader vendors: ScreenPoint, Lunit, DeepHealth/iCAD, Hologic Genius AI, Vara, Therapixel, CureMetrix, and related screening-AI assets.
  • Density, risk, and population-health AI platforms: Lunit/Volpara, Clairity, Densitas, b-rayZ, ScreenPoint/Biomediq, and DeepHealth.
  • Enterprise imaging, breast workflow, and AI orchestration platforms: Visage/Pro Medicus, Sectra, Fujifilm Synapse, Intelerad, GE, Siemens, Philips, Mach7, Agfa, Hyland, and related platforms.
  • Interventional breast pathway and biopsy ecosystem: Hologic, Mammotome, BD, Merit Medical, Leica/Danaher, GE, Siemens, and related procedure assets.
  • Provider networks, mobile access, and telemammography operators: RadNet/DeepHealth, Solis, SimonMed, Mamotest-like models, Krsnaa-like PPP models, and public mobile screening programs.
  • Detector, CEM, and photon-counting enabling stack: Siemens, Canon/Redlen, Varex, GE, Hologic, detector suppliers, contrast suppliers, and selected enabling-technology owners.

The report’s competitive conclusion is that no single company controls every layer. Hologic remains the strongest vertical breast-health incumbent, GE and Siemens are credible enterprise and CEM/premium-technology challengers, software and AI platforms increasingly influence reading workflow, and China/value-tier players create a different unit-versus-value competitive tension.

What's Inside

Core model: 2024A–2035F

  • Procedure volume
  • Installed base
  • Annual shipments
  • Equipment / gantry revenue
  • Service contracts
  • Mammography-specific software and workstations
  • AI / workflow software
  • Core Mammography Market
  • Interventional Breast Pathway
  • Breast Ultrasound Adjacency
  • Breast MRI Adjacency
  • Breast Imaging Ecosystem Opportunity

Technology and workflow coverage

  • 2D FFDM
  • DBT / 3D mammography
  • Contrast-enhanced mammography
  • Mammography AI detection and second-reader workflows
  • Density and risk AI
  • Enterprise breast workflow and viewers
  • Mobile mammography and telemammography
  • Breast ultrasound and breast MRI adjacencies
  • Biopsy and interventional breast workflow
  • Photon-counting mammography as a scenario/watchlist technology, not a base-case revenue pool

Market-structure views

  • Core vs pathway vs ecosystem denominator
  • Regional and country market archetypes
  • Replacement-cycle dynamics
  • Screening-policy and utilization context
  • Procurement and tender evidence
  • Service and installed-base economics
  • CEM and premium overlay strategy
  • AI monetization and provider-gross value bridge
  • Competitive control-plane analysis

Strategic frameworks

The report applies Marketstrat’s Markintel® framework stack, including M³ Market Momentum Matrix, M-TEM, T-DIC, Solution Adoption & Growth Matrix, ARC-Index, Ecosystem Collaboration Matrix, and Upgrade & Package Ladder. These frameworks translate model outputs into strategic interpretation: which segments deserve investment, where pricing risk is highest, where AI can be monetized, and which technologies are commercially ready versus evidence- or reimbursement-gated.

Geographic coverage

Global, North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, plus major countries and named clusters analyzed in the report. The regional model distinguishes mature replacement markets, access-expansion markets, screening-program markets, premium private-network markets, public/value procurement markets, and China’s two-channel structure.

Why This Report?

This report is designed for decision-makers with commercial, product, operational, investment, or strategic exposure to mammography and breast imaging, including:

  • Mammography OEM strategy, product, commercial, and corporate development teams
  • Breast health platform companies
  • AI detection, density/risk, workflow, and orchestration vendors
  • Enterprise imaging, PACS, viewer, and reporting platforms
  • Breast biopsy, localization, and interventional pathway companies
  • Detector, CEM, contrast, and enabling-technology suppliers
  • Provider networks, imaging centers, mobile screening operators, and teleradiology platforms
  • Investors, banks, private equity, and strategic acquirers
  • Distributors and regional channel partners
  • Public-sector screening, procurement, and access-infrastructure stakeholders

The report is not only a market-sizing document. It is a strategic map of how value is shifting around mammography: from hardware placement toward service, workflow, AI, CEM, biopsy, enterprise viewing, provider-volume economics, mobile access, and supplemental imaging routing.

Report Details

  • Title: Global Mammography Horizon: Market Structure, Forecasts, Competitive Dynamics, and AI Monetization Architecture, 2024A–2035F
  • Type: Marketstrat® Horizon Report
  • Report ID: MINTH-M02137
  • Publication: July 2026
  • Forecast Horizon: 2024A–2035F
  • Format: PDF digital delivery
  • Core Coverage: Mammography systems, FFDM, DBT, CEM, mammography AI/workflow, service and aftermarket, mobile mammography, interventional breast pathway, breast ultrasound, and breast MRI adjacencies
  • Geographic Coverage: Global, North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, plus major countries and named regional clusters
  • License Options: Individual ($4,950), Team ($5,450), Enterprise ($8,950)
Show more
Product Code: MINTH-M02137

Table of Contents

SECTION 1 – EXECUTIVE SUMMARY

  • 1.1 EXECUTIVE TAKEAWAYS
  • 1.2 THE 25-SECOND READ
  • 1.3 GLOBAL MARKET AT-A-GLANCE
  • 1.4 WHAT IS STRUCTURALLY CHANGING
  • 1.5 REGIONAL ARCHETYPES
  • 1.6 COMPETITIVE LANDSCAPE AT-A-GLANCE
  • 1.7 IMPLICATIONS-TO-ACTION
  • 1.8 SIGNALS TO WATCH OVER THE NEXT 12–24 MONTHS

SECTION 2 - RESEARCH & METHODOLOGY

  • 2.1 PURPOSE OF THE REPORT
  • 2.2 WHAT THIS REPORT IS - AND WHAT IT IS NOT
  • 2.3 RESEARCH FOUNDATION AND SOURCE STACK
  • 2.4 MARKET DEFINITION AND SEGMENTATION SCHEMA
  • 2.6 CORE MARKET SIZING AND FORECASTING METHODOLOGY
  • 2.7 AI / WORKFLOW METHODOLOGY
  • 2.8 REGIONAL FORECAST METHODOLOGY
  • 2.9 COMPETITIVE LANDSCAPE METHODOLOGY
  • 2.10 QA, RECONCILIATION, AND LIMITATIONS

SECTION 3 - WORLD MARKET STRUCTURE AND STRATEGIC FRAMEWORKS

  • 3.1 STRATEGIC THESIS
  • 3.2 GLOBAL MARKET SNAPSHOT
  • 3.3 GROWTH DRIVERS
  • 3.4 GROWTH CONSTRAINTS
  • 3.5 REGIONAL MARKET STRUCTURE
  • 3.6 M³ MARKET MOMENTUM MATRIX - REVENUE POOLS
  • 3.7 M-TEM - TECHNOLOGY MATURITY SCORING
  • 3.8 T-DIC - TECHNOLOGY DIFFUSION AND IMPACT CURVE
  • 3.9 SOLUTION ADOPTION & GROWTH MATRIX
  • 3.10 ARC-INDEX - COMMERCIALIZATION READINESS
  • 3.11 AI MONETIZATION MAP
  • 3.12 UPGRADE & PACKAGE LADDER
  • 3.13 ECOSYSTEM COLLABORATION MAP
  • 3.14 STRATEGIC FRAMEWORKS CLOSING SYNTHESIS

SECTION 4 - COMPETITIVE LANDSCAPE

  • 4.1 COMPETITIVE THESIS: MAMMOGRAPHY IS SHIFTING FROM SHARE OF GANTRIES TO SHARE OF CONTROL PLANES
  • 4.2 COMPETITIVE ARCHITECTURE: EIGHT CLUSTERS DEFINE THE MARKET
  • 4.3 COMPETITIVE CONTROL-PLANE SCORECARD
  • 4.4 MARKETSTRAT COMPETITIVE INSIGHT: FIVE WAYS MAMMOGRAPHY COMPETITION IS DIFFERENT
  • 4.5 CLUSTER 1 - SYSTEMS OEMS / BREAST HEALTH PLATFORM INCUMBENTS
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • What It Takes to Win in Cluster 1
    • Hologic
    • GE HealthCare
    • Siemens Healthineers
    • Fujifilm
    • Canon Medical
    • Planmed
    • IMS/Giotto
    • Cluster 1 Strategic Takeaways
    • 4.6 CLUSTER 2 - CHINA / VALUE-TIER MAMMOGRAPHY CHALLENGERS
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • What It Takes to Win in Cluster 2
    • United Imaging
    • Wandong
    • Mindray
    • Neusoft
    • Cluster 2 Strategic Takeaways
  • 4.7 CLUSTER 3 - BREAST AI DETECTION AND SECOND-READER VENDORS
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • ScreenPoint Medical
    • Lunit / Volpara
    • RadNet / DeepHealth / iCAD
    • Hologic Genius AI
    • Vara
    • Therapixel / MammoScreen
    • CureMetrix
    • Cluster 3 Strategic Takeaways
  • 4.8 CLUSTER 4 - DENSITY, RISK, AND POPULATION-HEALTH AI PLATFORMS
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • Lunit / Volpara
    • Clairity
    • Densitas
    • b-rayZ
    • DeepHealth
    • Cluster 4 Strategic Takeaways
  • 4.9 CLUSTER 5 - ENTERPRISE IMAGING, BREAST WORKFLOW, AND AI ORCHESTRATION PLATFORMS
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • Visage / Pro Medicus
    • Sectra
    • Fujifilm Synapse
    • Intelerad (GEHC)
    • GE HealthCare Enterprise Workflow
    • Siemens Healthineers Workflow
    • Aidoc aiOS and AI Orchestration Platforms
    • Cluster 5 Strategic Takeaways
  • 4.10 CROSS-CLUSTER SYNTHESIS - SOFTWARE CONTROL PLANES
  • 4.11 SOFTWARE CLUSTER CLOSING SYNTHESIS
  • 4.12 CLUSTER 6 - INTERVENTIONAL BREAST PATHWAY AND BIOPSY ECOSYSTEM
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • Hologic
    • Mammotome
    • BD
    • Merit Medical
    • GE HealthCare
    • Siemens Healthineers
    • Cluster 6 Strategic Takeaways
  • 4.13 CLUSTER 7 - PROVIDER NETWORKS, MOBILE ACCESS, AND TELEMAMMOGRAPHY OPERATORS
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • RadNet / DeepHealth
    • Solis Mammography
    • SimonMed Imaging
    • Mamotest-like Telemammography Platforms
    • Krsnaa-like PPP Diagnostic Networks
    • Public Mobile Screening Programs
    • Cluster 7 Strategic Takeaways
  • 4.14 CLUSTER 8 - DETECTOR, CEM, AND PHOTON-COUNTING ENABLING STACK
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • GE HealthCare
    • Hologic
    • Siemens Healthineers
    • Canon / Redlen
    • Varex / Direct Conversion
    • Calidar
    • Bayer, Bracco, and Guerbet
    • United Imaging
    • Cluster 8 Strategic Takeaways
  • 4.15 CROSS-CLUSTER SYNTHESIS - DOWNSTREAM AND ENABLING CONTROL PLANES
  • 4.16 DOWNSTREAM AND ENABLING CONTROL PLANES - CLOSING SYNTHESIS
  • 4.17 COMPETITIVE CAPSTONE - FROM VENDOR RANKING TO STRATEGIC CONTROL
    • Key Takeaways
  • 4.18 GTM GROWTH–MATURITY MATRIX - MAMMOGRAPHY ECOSYSTEM PLAYERS
    • Framework Definition
    • Competitive Context
    • Strategic Takeaways - GTM Growth–Maturity Matrix
  • 4.19 COMPETITIVE EXPOSURE HEATMAP
    • Purpose of the Exposure Heatmap
    • Exposure Heatmap Interpretation
  • 4.20 COMPETITIVE STANCE BY PLAYER TYPE
  • 4.21 WHERE-TO-WIN COMPETITIVE MAP
  • 4.22 COMPETITIVE MOAT DURABILITY LADDER
    • Moat Interpretation
  • 4.23 COMPETITIVE PLAYBOOK BY COMPANY CLUSTER
  • 4.24 INSIGHTS-TO-ACTION BY STAKEHOLDER
  • 4.25 COMPETITIVE SIGNALS TO WATCH OVER THE NEXT 12–24 MONTHS
  • 4.26 FINAL COMPETITIVE SYNTHESIS

SECTION 5 - REGIONAL AND COUNTRY MARKET ANALYSIS

  • 5.1 GLOBAL REGIONAL LENS: MAMMOGRAPHY IS A LOCAL POLICY MARKET WITH GLOBAL PLATFORM ECONOMICS
    • Global Forecast Summary by Region
    • Regional Market Archetypes
  • 5.2 NORTH AMERICA REGIONAL ANALYSIS
    • Key Takeaways
    • North America Market Landscape
    • North America Market Snapshot
    • Demand, Screening, and Socioeconomic Context
    • North America Bottom Line
  • 5.3 UNITED STATES COUNTRY ANALYSIS
    • U.S. Market Landscape
    • U.S. Market Forecast
    • U.S. Installed Base, Utilization, and Replacement Economics
    • U.S. Screening Policy, Regulation, and Reimbursement Context
    • U.S. Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • U.S. Competitive and Channel Dynamics
    • U.S. Growth Drivers and Constraints
    • U.S. Bottom Line
  • 5.4 CANADA COUNTRY ANALYSIS
    • Canada Market Landscape
    • Canada Market Forecast
    • Canada Health-System, Screening, and Procurement Context
    • Canada Installed Base, Utilization, and Replacement Economics
    • Canada Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • Canada Competitive and Channel Dynamics
    • Canada Growth Drivers and Constraints
    • Canada Bottom Line
  • 5.5 EUROPE REGIONAL ANALYSIS
    • Key Takeaways
    • Europe Market Landscape
    • Disease, Demographic, and Screening Context
    • Health-System, Reimbursement, and Procurement Context
    • Installed Base, Utilization, and Replacement Economics
    • Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • Competitive and Channel Dynamics
    • Europe Growth Drivers and Constraints
    • Europe Bottom Line
  • 5.6 GERMANY COUNTRY ANALYSIS
    • Key Takeaways
    • Germany Market Landscape
    • Germany Market Forecast
    • Germany Disease and Demographic Demand Context
    • Germany Health-System, Reimbursement, and Procurement Context
    • Germany Installed Base, Utilization, and Replacement Economics
    • Germany Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • Germany Competitive and Channel Dynamics
    • Germany Growth Drivers and Constraints
    • Germany Bottom Line
  • 5.7 FRANCE COUNTRY ANALYSIS
    • Key Takeaways
    • France Market Landscape
    • France Market Forecast
    • France Disease and Demographic Demand Context
    • France Health-System, Reimbursement, and Procurement Context
    • France Installed Base, Utilization, and Replacement Economics
    • France Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • France Competitive and Channel Dynamics
    • France Growth Drivers and Constraints
    • France Bottom Line
  • 5.8 UNITED KINGDOM COUNTRY ANALYSIS
    • Key Takeaways
    • United Kingdom Market Landscape & Forecast
    • United Kingdom Disease and Demographic Demand Context
    • United Kingdom Health-System, Reimbursement, and Procurement Context
    • United Kingdom Installed Base, Utilization, and Replacement Economics
    • United Kingdom Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • United Kingdom Competitive and Channel Dynamics
    • United Kingdom Growth Drivers and Constraints
    • United Kingdom Bottom Line
  • 5.9 ITALY COUNTRY ANALYSIS
    • Key Takeaways
    • Italy Market Landscape & Forecast
    • Italy Disease and Demographic Demand Context
    • Italy Health-System, Reimbursement, and Procurement Context
    • Italy Installed Base, Utilization, and Replacement Economics
    • Italy Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • Italy Competitive and Channel Dynamics
    • Italy Growth Drivers and Constraints
    • Italy Bottom Line
  • 5.10 REST OF EUROPE NAMED CLUSTERS
    • Cluster Overview
    • Market Forecast by Cluster - ROE
    • Spain / Iberia
    • Nordics
    • Benelux
    • Central and Eastern Europe
    • EUROPE CLOSING SYNTHESIS
  • 5.11 ASIA-PACIFIC REGIONAL ANALYSIS
    • Key Takeaways
    • APAC Market Landscape
    • APAC Market Forecast by Revenue Pool / Market View
    • APAC Market Forecast by Country/Regional Cluster
    • APAC Demand, Screening, and Socioeconomic Context
    • APAC Health-System, Reimbursement, and Procurement Context
    • APAC Installed Base, Utilization, and Replacement Economics
    • APAC Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • APAC Competitive and Channel Dynamics
    • APAC Growth Drivers and Constraints
    • APAC Bottom Line
  • 5.12 CHINA COUNTRY ANALYSIS
    • Key Takeaways
    • China Market Landscape & Forecast
    • China Disease and Demographic Demand Context
    • China Health-System, Reimbursement, and Procurement Context
    • China Two-Channel Market Structure
    • China Installed Base, Utilization, and Replacement Economics
    • China Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • China Competitive and Channel Dynamics
    • China Growth Drivers and Constraints
    • China Bottom Line
  • 5.13 JAPAN COUNTRY ANALYSIS
    • Key Takeaways
    • Japan Market Landscape & Forecast
    • Japan Disease and Demographic Demand Context
    • Japan Health-System, Reimbursement, and Procurement Context
    • Japan Installed Base, Utilization, and Replacement Economics
    • Japan Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • Japan Competitive and Channel Dynamics
    • Japan Growth Drivers and Constraints
    • Japan Bottom Line
  • 5.14 INDIA COUNTRY ANALYSIS
    • Key Takeaways
    • India Market Landscape & Forecast
    • India Disease and Demographic Demand Context
    • India Health-System, Reimbursement, and Procurement Context
    • India Installed Base, Utilization, and Replacement Economics
    • India Technology Adoption: FFDM, DBT, CEM, AI, Breast US, and Mobile
    • India Competitive and Channel Dynamics
    • India Growth Drivers and Constraints
    • India Bottom Line
  • 5.15 SOUTH KOREA COUNTRY ANALYSIS
    • Key Takeaways
    • South Korea Market Landscape & Forecast
    • South Korea Disease and Demographic Demand Context
    • South Korea Health-System, Reimbursement, and Procurement Context
    • South Korea Installed Base, Utilization, and Replacement Economics
    • South Korea Technology Adoption: DBT, CEM, AI, Breast US, and Mobile
    • South Korea Competitive and Channel Dynamics
    • South Korea Growth Drivers and Constraints
    • South Korea Bottom Line
  • 5.16 AUSTRALIA COUNTRY ANALYSIS
    • Key Takeaways
    • Australia Market Landscape
    • Australia Disease and Demographic Demand Context
    • Australia Health-System, Reimbursement, and Procurement Context
    • Australia Installed Base, Utilization, and Replacement Economics
    • Australia Technology Adoption: DBT, CEM, AI, Breast US/MRI, and Mobile
    • Australia Competitive and Channel Dynamics
    • Australia Growth Drivers and Constraints
    • Australia Bottom Line
  • 5.17 REST OF APAC (ROAPAC) NAMED CLUSTERS
    • Cluster Overview
    • Rest of APAC Forecast by Regional Cluster
    • Advanced ROAPAC
    • ASEAN
    • South Asia ex-India
    • Other Emerging APAC
    • ROAPAC Closing Synthesis
  • 5.18 LATIN AMERICA REGIONAL ANALYSIS
    • Key Takeaways
    • LATAM Market Landscape & Forecast
    • LATAM Demand, Screening, and Socioeconomic Context
    • LATAM Health-System, Reimbursement, and Procurement Context
    • LATAM Installed Base, Utilization, and Replacement Economics
    • LATAM Technology Adoption: FFDM, DBT, CEM, AI, Breast US/MRI, and Mobile
    • LATAM Competitive and Channel Dynamics
    • LATAM Growth Drivers and Constraints
    • LATAM Bottom Line
  • 5.19 BRAZIL COUNTRY ANALYSIS
    • Key Takeaways
    • Brazil Market Landscape & Forecast
    • Brazil Demand and Screening Context
    • Brazil Health-System, Reimbursement, and Procurement Context
    • Brazil Technology Adoption: FFDM, DBT, CEM, AI, Breast US/MRI, and Mobile
    • Brazil Competitive and Channel Dynamics
    • Brazil Growth Drivers and Constraints
    • Brazil Bottom Line
  • 5.20 MEXICO COUNTRY ANALYSIS
    • Key Takeaways
    • Mexico Market Landscape & Forecast
    • Mexico Demand and Screening Context
    • Mexico Health-System, Reimbursement, and Procurement Context
    • Mexico Installed Base, Utilization, and Replacement Economics
    • Mexico Technology Adoption: FFDM, DBT, CEM, AI, Breast US/MRI, and Mobile
    • Mexico Competitive and Channel Dynamics
    • Mexico Growth Drivers and Constraints
    • Mexico Bottom Line
  • 5.21 REST OF LATAM NAMED CLUSTER
    • Cluster Overview
    • Rest of LATAM Forecast by Revenue Pool/Market View
    • Rest of LATAM Market Structure and Strategic Readiness
    • Rest of LATAM Bottom Line
  • 5.22 MIDDLE EAST & AFRICA REGIONAL ANALYSIS
    • Key Takeaways
    • MEA Market Landscape
    • MEA Forecast by Revenue Pool / Market View
    • MEA Demand, Screening, and Socioeconomic Context
    • MEA Health-System, Reimbursement, and Procurement Context
    • MEA Installed Base, Utilization, and Replacement Economics
    • MEA Technology Adoption: FFDM, DBT, CEM, AI, Breast US/MRI, and Mobile
    • MEA Competitive and Channel Dynamics
    • MEA Growth Drivers and Constraints
    • MEA Bottom Line
  • 5.23 GCC NAMED CLUSTER
    • Cluster Overview
    • GCC Forecast by Revenue Pool / Market View
    • GCC Market Structure and Strategic Readiness
    • GCC Bottom Line
  • 5.24 SOUTH AFRICA COUNTRY ANALYSIS
    • Key Takeaways
    • South Africa Market Landscape & Forecast
    • South Africa Demand and Screening Context
    • South Africa Health-System, Reimbursement, and Procurement Context
    • South Africa Installed Base, Utilization, and Replacement Economics
    • South Africa Technology Adoption: Mammography, Ultrasound, Biopsy, AI, and Mobile
    • South Africa Competitive and Channel Dynamics
    • South Africa Growth Drivers and Constraints
    • South Africa Bottom Line
  • 5.25 REST OF MEA ACCESS-INFRASTRUCTURE CLUSTER
    • Cluster Overview
    • Rest of MEA Forecast
    • Rest of MEA Market Structure and Strategic Readiness Rest of MEA Bottom Line

SECTION 5 CLOSING SYNTHESIS - REGIONAL STRATEGY IMPLICATIONS

Show more
Product Code: MINTH-M02137

List of Figures

  • FIGURE 1: EXECUTIVE “SO-WHAT” DASHBOARD
  • FIGURE 2: GLOBAL MAMMOGRAPHY MARKET ECOSYSTEM ARCHITECTURE
  • FIGURE 3: REGIONAL ARCHETYPE SCALE AND GROWTH MAP
  • FIGURE 4: FRONTIER TECHNOLOGY WATCHLIST
  • FIGURE 5: AI VENDOR-NET TO PROVIDER-GROSS VALUE BRIDGE
  • FIGURE 6: CORE MAMMOGRAPHY MARKET MIX SHIFT
  • FIGURE 7: BREAST IMAGING ECOSYSTEM ENRICHMENT RATIO
  • FIGURE 8: MAMMOGRAPHY GROWTH CONTRIBUTION AND VALUE MIGRATION
  • FIGURE 9: CEM, MRI, AND ULTRASOUND DIAGNOSTIC PATHWAY COMPARISON
  • FIGURE 10: M³ MARKET MOMENTUM MATRIX - MAMMOGRAPHY REVENUE POOLS
  • FIGURE 11: M-TEM TECHNOLOGY MATURITY HEATMAP
  • FIGURE 12: COMPETITIVE CONTROL-PLANE SCORECARD
  • FIGURE 13: T-DIC TECHNOLOGY DIFFUSION AND IMPACT CURVE
  • FIGURE 14: ARC-INDEX COMMERCIALIZATION READINESS
  • FIGURE 15: MAMMOGRAPHY UPGRADE & PACKAGE LADDER
  • FIGURE 16: FROM SHARE OF GANTRIES TO SHARE OF CONTROL PLANES
  • FIGURE 17: THE MAMMOGRAPHY MARKET IS EIGHT CONTROL PLANES, NOT ONE
  • FIGURE 18: STRATEGIC CONTROL PLANE POSITION
  • FIGURE 19: INCUMBENT EXPOSURE ACROSS THE EIGHT CONTROL PLANES
  • FIGURE 20: U.S. REPLACEMENT CYCLE AND ENVISION EXPOSURE MAP
  • FIGURE 21: BREAST AI PLATFORM CONSOLIDATION MAP
  • FIGURE 22: BREAST AI EVIDENCE AND DEPLOYMENT READINESS MAP
  • FIGURE 23: INTERVENTIONAL BREAST PATHWAY CONTROL-PLANE MAP
  • FIGURE 24: MOBILE AND TELEMAMMOGRAPHY ACCESS MODEL MAP
  • FIGURE 25: CEM-GUIDED BIOPSY PATHWAY MAP
  • FIGURE 26: GTM GROWTH–MATURITY MATRIX - MAMMOGRAPHY ECOSYSTEM PLAYERS
  • FIGURE 27: COUNTRY ARCHETYPE TILES
  • FIGURE 28: COMPETITIVE EXPOSURE HEATMAP
  • FIGURE 29: REGIONAL WHERE-TO-WIN HEATMAP
  • FIGURE 30: U.S. HOLOGIC INSTALLED BASE AND REPLACEMENT ECONOMICS
  • FIGURE 31: EUROPE SCREENING AI READINESS MAP
  • FIGURE 32: CHINA TWO-CHANNEL PROCUREMENT MAP
  • FIGURE 33: CHINA PUBLIC/VALUE PRESSURE AND PREMIUM DEFENSE MAP

List of Tables

  • TABLE 1: GLOBAL MAMMOGRAPHY EXECUTIVE DASHBOARD, 2024A–2035F
  • TABLE 2: GLOBAL MAMMOGRAPHY MARKET AT-A-GLANCE, 2024A–2035F
  • TABLE 3: VALUE MIGRATION IN MAMMOGRAPHY - FROM SYSTEM SALE TO BREAST IMAGING OPERATING SYSTEM
  • TABLE 4: GLOBAL MAMMOGRAPHY REGIONAL ARCHETYPES
  • TABLE 5: COMPETITIVE LANDSCAPE AT-A-GLANCE - STRATEGIC CONTROL PLANES
  • TABLE 6: EXECUTIVE IMPLICATIONS-TO-ACTION BY STAKEHOLDER
  • TABLE 7: MAMMOGRAPHY MARKET SIGNALS TO WATCH
  • TABLE 8: STANDARDIZED SOURCE STACK AND USAGE RULES
  • TABLE 9: MAMMOGRAPHY MARKET DEFINITION AND DENOMINATOR SCHEMA
  • TABLE 10: REVENUE STREAM DEFINITIONS USED IN THE FORECAST
  • TABLE 11: CORE FORECAST CONSTRUCTION LOGIC
  • TABLE 12: AI / WORKFLOW MONETIZATION ARCHITECTURE
  • TABLE 13: AI VALUE BRIDGE - VENDOR-NET REVENUE VS PROVIDER-GROSS ECONOMICS (USD MILLIONS)
  • TABLE 14: REGIONAL FORECAST ARCHETYPE METHODOLOGY
  • TABLE 15: COMPETITIVE ASSESSMENT METHODOLOGY
  • TABLE 16: FORECAST QA AND INTERPRETATION GUARDRAILS
  • TABLE 17: GLOBAL MAMMOGRAPHY REVENUE FORECAST BY STREAM, 2024A–2035F (USD MILLIONS)
  • TABLE 18: GLOBAL BREAST IMAGING ECOSYSTEM OPPORTUNITY, 2024A–2035F (USD MILLIONS)
  • TABLE 19: GLOBAL DEMAND, INSTALLED BASE, AND SHIPMENT METRICS, 2024A–2035F
  • TABLE 20: GLOBAL MAMMOGRAPHY GROWTH DRIVERS
  • TABLE 21: GLOBAL MAMMOGRAPHY GROWTH CONSTRAINTS
  • TABLE 22: REGIONAL FORECAST SUMMARY - CORE MAMMOGRAPHY MARKET AND BREAST IMAGING ECOSYSTEM OPPORTUNITY (USD MILLIONS)
  • TABLE 23: M³ MARKET MOMENTUM MATRIX - MAMMOGRAPHY REVENUE POOLS
  • TABLE 24: SEGMENT MOMENTUM SNAPSHOT - REVENUE POOLS
  • TABLE 25: M-TEM SCORECARD - MAMMOGRAPHY TECHNOLOGY STACK
  • TABLE 26: T-DIC - MAMMOGRAPHY TECHNOLOGY DIFFUSION AND IMPACT CURVE
  • TABLE 27: SOLUTION ADOPTION & GROWTH MATRIX - MAMMOGRAPHY AI / WORKFLOW / TECHNOLOGY USE CASES
  • TABLE 28: ARC-INDEX - MAMMOGRAPHY TECHNOLOGIES AND AI / WORKFLOW USE CASES (SCORING SCALE: 0–100)
  • TABLE 29: MAMMOGRAPHY AI USE-CASE MONETIZATION MAP
  • TABLE 30: MAMMOGRAPHY UPGRADE & PACKAGE LADDER - COMMERCIAL PACKAGING ARCHITECTURE
  • TABLE 31: ECOSYSTEM COLLABORATION MAP - MAMMOGRAPHY CONTROL PLANES
  • TABLE 32: MAMMOGRAPHY COMPETITIVE LANDSCAPE MAP - CLUSTER ARCHITECTURE
  • TABLE 33: MAMMOGRAPHY COMPETITIVE CONTROL-PLANE SCORECARD
  • TABLE 34: FIVE COMPETITIVE MODELS IN MAMMOGRAPHY
  • TABLE 35: SYSTEMS OEM WINNING FACTORS
  • TABLE 36: CHINA / VALUE-TIER CHALLENGER WINNING FACTORS
  • TABLE 37: BREAST AI DETECTION AND SECOND-READER CLUSTER - COMPETITIVE FACTORS
  • TABLE 38: BREAST AI DETECTION AND SECOND-READER VENDORS - COMPETITIVE DATASET
  • TABLE 39: BREAST AI DETECTION CLUSTER - WHAT IT TAKES TO WIN
  • TABLE 40: DENSITY, RISK, AND POPULATION-HEALTH AI CLUSTER - COMPETITIVE FACTORS
  • TABLE 41: DENSITY, RISK, AND POPULATION-HEALTH AI VENDORS - COMPETITIVE DATASET
  • TABLE 42: DENSITY / RISK AI - HOW VALUE FLOWS INTO THE BREAST IMAGING ECOSYSTEM
  • TABLE 43: ENTERPRISE IMAGING AND BREAST WORKFLOW CLUSTER - COMPETITIVE FACTORS
  • TABLE 44: ENTERPRISE IMAGING AND BREAST WORKFLOW PLATFORMS - COMPETITIVE DATASET
  • TABLE 45: MAMMOGRAPHY WORKFLOW CONTROL - OEM WORKSTATION VS ENTERPRISE VIEWER VS AI ORCHESTRATION
  • TABLE 46: SOFTWARE CONTROL-PLANE MAP - WHO CONTROLS WHAT?
  • TABLE 47: SOFTWARE CLUSTER GROWTH–MATURITY POSITIONING
  • TABLE 48: SOFTWARE CLUSTER STRATEGIC TAKEAWAYS - DETECTION, RISK, AND WORKFLOW
  • TABLE 49: INTERVENTIONAL BREAST PATHWAY - COMPETITIVE FACTORS
  • TABLE 50: INTERVENTIONAL BREAST PATHWAY - COMPETITIVE DATASET
  • TABLE 51: INTERVENTIONAL BREAST PATHWAY - WHAT IT TAKES TO WIN
  • TABLE 52: PROVIDER NETWORKS, MOBILE ACCESS, AND TELEMAMMOGRAPHY - COMPETITIVE FACTORS
  • TABLE 53: PROVIDER NETWORKS, MOBILE ACCESS, AND TELEMAMMOGRAPHY - COMPETITIVE DATASET
  • TABLE 54: MOBILE MAMMOGRAPHY AND TELEMAMMOGRAPHY - MARKET STRUCTURE VIEW
  • TABLE 55: DETECTOR, CEM, AND PHOTON-COUNTING ENABLING STACK - COMPETITIVE FACTORS
  • TABLE 56: DETECTOR, CEM, AND PHOTON-COUNTING STACK - COMPETITIVE DATASET
  • TABLE 57: CEM, PCM, AND DETECTOR STACK - BASE CASE VS WATCHLIST TREATMENT
  • TABLE 58: DOWNSTREAM AND ENABLING CONTROL-PLANE MAP
  • TABLE 59: DOWNSTREAM AND ENABLING STRATEGIC TAKEAWAYS - WHERE COMPETITIVE ADVANTAGE MOVES DOWNSTREAM.
  • TABLE 60: GTM GROWTH–MATURITY QUADRANT DEFINITIONS
  • TABLE 61: GTM GROWTH–MATURITY MATRIX - SELECTED MAMMOGRAPHY ECOSYSTEM PLAYERS
  • TABLE 62: GROWTH & MATURITY HIGHLIGHTS - SELECTED HIGH-IMPACT PLAYERS
  • TABLE 63: COMPETITIVE EXPOSURE HEATMAP - SELECTED MAMMOGRAPHY ECOSYSTEM PLAYERS
  • TABLE 64: HOW TO INTERPRET THE EXPOSURE HEATMAP
  • TABLE 65: COMPETITIVE STANCE BY PLAYER TYPE - STRATEGIC POSTURE AND REQUIRED MOVES
  • TABLE 66: WHERE EACH PLAYER TYPE IS BEST POSITIONED TO WIN
  • TABLE 67: MAMMOGRAPHY COMPETITIVE MOAT DURABILITY LADDER
  • TABLE 68: COMPETITIVE PLAYBOOK - HOW EACH CLUSTER SHOULD ACT
  • TABLE 69: COMPETITIVE INSIGHTS-TO-ACTION
  • TABLE 70: COMPETITIVE SIGNALS TO WATCH
  • TABLE 71: GLOBAL REGIONAL FORECAST SUMMARY - CORE MAMMOGRAPHY MARKET AND BREAST IMAGING ECOSYSTEM OPPORTUNITY, 2024A–2035F (USD MILLIONS)
  • TABLE 72: REGIONAL MARKET ARCHETYPES - WHAT DRIVES VALUE BY GEOGRAPHY
  • TABLE 73: NORTH AMERICA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 74: NORTH AMERICA DEMAND AND SCREENING CONTEXT
  • TABLE 75: UNITED STATES MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 76: UNITED STATES DEMAND AND SCREENING CONTEXT
  • TABLE 77: UNITED STATES INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 78: UNITED STATES REGULATORY, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 79: UNITED STATES TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 80: UNITED STATES COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 81: UNITED STATES GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 82: CANADA DEMAND AND SCREENING CONTEXT
  • TABLE 83: CANADA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 84: CANADA HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 85: CANADA INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 86: CANADA TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 87: CANADA COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 88: CANADA GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 89: EUROPE MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 90: EUROPE DEMAND, DEMOGRAPHIC, AND SCREENING CONTEXT
  • TABLE 91: EUROPE HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 92: EUROPE INSTALLED BASE AND UTILIZATION ECONOMICS
  • TABLE 93: EUROPE TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 94: EUROPE COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 95: EUROPE GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 96: GERMANY MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 97: GERMANY DEMAND AND SCREENING CONTEXT
  • TABLE 98: GERMANY HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 99: GERMANY INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 100: GERMANY TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 101: GERMANY COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 102: GERMANY GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 103: FRANCE MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 104: FRANCE DEMAND AND SCREENING CONTEXT
  • TABLE 105: FRANCE HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 106: FRANCE INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 107: FRANCE TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 108: FRANCE COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 109: FRANCE GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 110: UNITED KINGDOM MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 111: UNITED KINGDOM DEMAND AND SCREENING CONTEXT
  • TABLE 112: UNITED KINGDOM HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 113: UNITED KINGDOM INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 114: UNITED KINGDOM TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 115: UNITED KINGDOM COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 116: UNITED KINGDOM GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 117: ITALY MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 118: ITALY DEMAND AND SCREENING CONTEXT
  • TABLE 119: ITALY HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 120: ITALY INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 121: ITALY TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 122: ITALY COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 123: ITALY GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 124: EUROPE NAMED-CLUSTER FORECAST SUMMARY, 2024A–2035F (USD MILLIONS)
  • TABLE 125: SPAIN / IBERIA MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 126: NORDICS MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 127: BENELUX MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 128: CENTRAL AND EASTERN EUROPE MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 129: EUROPE NAMED-CLUSTER COMMERCIAL PLAYBOOK
  • TABLE 130: ASIA-PACIFIC MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 131: APAC COUNTRY AND NAMED-CLUSTER FORECAST SUMMARY, 2024A–2035F (USD MILLIONS)
  • TABLE 132: APAC DEMAND, SCREENING, AND POLICY CONTEXT
  • TABLE 133: APAC HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 134: APAC INSTALLED BASE AND UTILIZATION ECONOMICS
  • TABLE 135: APAC TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 136: APAC COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 137: APAC GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 138: CHINA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 139: CHINA DEMAND AND SCREENING CONTEXT
  • TABLE 140: CHINA HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 141: CHINA TWO-CHANNEL MAMMOGRAPHY MARKET STRUCTURE
  • TABLE 142: CHINA INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 143: CHINA TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 144: CHINA COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 145: CHINA GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 146: JAPAN MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 147: JAPAN DEMAND AND SCREENING CONTEXT
  • TABLE 148: JAPAN HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 149: JAPAN INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 150: JAPAN TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 151: JAPAN COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 152: JAPAN GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 153: INDIA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 154: INDIA DEMAND AND SCREENING CONTEXT
  • TABLE 155: INDIA HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 156: INDIA INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 157: INDIA TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 158: INDIA COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 159: INDIA GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 160: SOUTH KOREA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 161: SOUTH KOREA DEMAND AND SCREENING CONTEXT
  • TABLE 162: SOUTH KOREA HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 163: SOUTH KOREA INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 164: SOUTH KOREA TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 165: SOUTH KOREA COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 166: SOUTH KOREA GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 167: AUSTRALIA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 168: AUSTRALIA DEMAND AND SCREENING CONTEXT
  • TABLE 169: AUSTRALIA HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 170: AUSTRALIA INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 171: AUSTRALIA TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 172: AUSTRALIA COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 173: AUSTRALIA GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 174: ROAPAC NAMED-CLUSTER FORECAST SUMMARY, 2024A–2035F (USD MILLIONS)
  • TABLE 175: ADVANCED ROAPAC MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 176: ASEAN MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 177: SOUTH ASIA EX-INDIA MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 178: OTHER EMERGING APAC MARKET STRUCTURE AND STRATEGIC READINESS
  • ABLE 179: ROAPAC COMMERCIAL PLAYBOOK - WHAT EACH CLUSTER REWARDS
  • TABLE 180: LATIN AMERICA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 181: LATAM DEMAND, SCREENING, AND POLICY CONTEXT
  • TABLE 182: LATAM HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 183: LATAM INSTALLED BASE AND UTILIZATION ECONOMICS
  • TABLE 184: LATAM TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 185: LATAM COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 186: LATAM GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 187: BRAZIL MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 188: BRAZIL DEMAND AND SCREENING CONTEXT
  • TABLE 189: BRAZIL HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 190: BRAZIL INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 191: BRAZIL TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 192: BRAZIL COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 193: BRAZIL GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 194: MEXICO MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 195: MEXICO DEMAND AND SCREENING CONTEXT
  • TABLE 196: MEXICO HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 197: MEXICO INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 198: MEXICO TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 199: MEXICO COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 200: MEXICO GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 201: REST OF LATAM MARKET FORECAST SUMMARY, 2024A–2035F (USD MILLIONS)
  • TABLE 202: REST OF LATAM MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 203: MIDDLE EAST & AFRICA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 204: MEA DEMAND, SCREENING, AND POLICY CONTEXT
  • TABLE 205: MEA HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 206: MEA INSTALLED BASE AND UTILIZATION ECONOMICS
  • TABLE 207: MEA TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 208: MEA COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 209: MEA GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 210: GCC MAMMOGRAPHY MARKET FORECAST SUMMARY, 2024A–2035F (USD MILLIONS)
  • TABLE 211: GCC MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 212: SOUTH AFRICA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 213: SOUTH AFRICA DEMAND AND SCREENING CONTEXT
  • TABLE 214: SOUTH AFRICA HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 215: SOUTH AFRICA INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 216: SOUTH AFRICA TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 217: SOUTH AFRICA COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 218: SOUTH AFRICA GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 219: REST OF MEA MARKET FORECAST SUMMARY, 2024A–2035F (USD MILLIONS)
  • TABLE 220: REST OF MEA MARKET STRUCTURE AND STRATEGIC READINESS
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!